Canbiola, Inc. (OTC PINK:
CANB) Revenue and Shareholder 2nd Quarter Update
HICKSVILLE, NY -- July 09, 2018 -- InvestorsHub NewsWire --
Canbiola, Inc. (OTC PINK: CANB) Canbiola is pleased to update
shareholders on our progress for the first half of 2018.
REVENUES:
We expect to have doubled our revenues in Q2 2018 as compared to
Q1 2018; our Distribution and Outreach strategy appears to be
beginning to take hold, and we are pleased with the progress and
expect to continue this upward swing moving forward.
DISTRIBUTION:
The Company's commitment to penetrate the medical community will
and always has been the foundation of our growth. This
decision has made a very positive impact to our Private Physician
Affiliate Program. Our corporate sales to Functional and
Alternative medical practices has grown. Our nationwide
Roll-Out has begun and continues to grow dramatically due to our
strong affiliation with very clear-cut distribution
channels. We see exponential growth to Doctors and Medical
Practices nationwide selling Canbiola products. We have developed a
new section on our site to help our potential clients locate
doctors and practices in their locality. This feature can be found
through our website
at https://canbiola.com/find-us-contact-us/.
MANUFACTURING:
We have acquired new equipment for use at the manufacturing
facility located in Washington State where the company’s products
are made. This allows the Company to roll out an entire new line of
supplements and varieties of other products. This equipment has
arrived at the location and installation is in progress. This
equipment will help us to control and expand the manufacturing
process in order to increase our efficiency and delivery
levels.
The latest equipment includes:
1. NJP-800 Automatic Capsule Filling Machine – Makes
48,000 dry capsules per hour and is GMP approved. Products: Hard
Capsules, allow any dry supplement blend that we create to be
encapsulated.
2. ZP-9 Rotary Tablet Press – Makes 12,000 tablets per
hour and is GMP approved. Products: Dab Tablets, Pet Tablets,
Coated Ibuprofen type tablets, hard press items like
Lifesavers.
3. 2M Conveyor Belt Line – Increases bottling and labeling
process by 25%
4. Small Capsule Counter ZN-400 – Counts/Fills 1,800
bottles of Capsules per hour. Fills capsule bottles with precision
for faster filling/sealing of hard capsules and dry tablets.
5. Additional Die Set for ZP-9 Tablet Press – Allows
'CANB' embossment for the Ibuprofen type coated dry tablets.
6. YD-2 Tablet Tester – Quality Control equipment that
determines optimum levels for dry tablets and Dab Tablets during
production.
7. BY-400 Coating Machine – Coatings for dry tablets made
by the ZP-9 machine to give Enteric coatings, buffers, and color to
the pressed hard tablets.
8. DPT-80 Blister Pack Machine – Makes 1,800 units per
hour. Setup for 6 or 8 sizes #0 dry capsules made with the NJP-8
machine, and allows us to pack the capsules in easy to tear
flat-packs with a thin box for shelves; will allow us to present
our products in smaller amounts like Tylenol cold medicine
liquid-gels, Sudafed etc.
9. DCJ Liquid Sachet Packing Machine – Makes 3,600 unites
per hour. The machine makes liquid packs of our items, such as
freeze-pops, freeze gel and lotion samples, tincture samples
and other liquid products we produce.
10. DCF Powder Sachet Packing Machine – Makes 3,600 units
per hour. The machine makes dry packs of our items, such as
retail-ready water-soluble powder for drink mixes, coffee, tea
smoothies, etc., in sugar-packet sizes.
11. SL-130 Automatic Labeling Machine – Rolls 6,000 labels
per hour. Auto Date Code and Conveyor Setup. Machine speeds up
labeling and allows us to use professional labels on all round
products.
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under
symbol CANB.
Canbiola, Inc. is a US Company embarking in the sale of a
variety of Cannabidiol (CBD) based products. Canbiola is in the
process of developing its own line of proprietary products as well
as seeking synergistic value through acquisitions in the CBD and
the medical cannabis industry. Cannabis is currently federally
illegal and has legalized for medical purposes in some form in a
limited number of states. The company has already launched several
products found at www.canbiola.com.
The company also owns two technological solutions, Wrapmail (US
Patent 8,572,275), which turns traditional email into a powerful
marketing and branding tool, as well Prosperity Systems and the
Bullseye platform of document management and compliance targeted at
broker-dealers, public companies, and governmental agencies
providing a flawless all-in-one solution for document management,
retention and compliance.
Forward-looking statements and risks and uncertainties Matters
discussed in this press release contain forward-looking statements.
The words "anticipate," "believe," "estimate," "may," "intend,"
"expect," and similar expressions identify such forward-looking
statements. Expected, actual results, performance, or achievements
could differ materially from those contemplated, expressed, or
implied by the forward-looking statements contained herein.
Forward-looking statements are subject to a number of risks and
uncertainties, including but not limited to, risks and
uncertainties associated with, among other things, the impact of
economic, competitive, and other factors affecting our operations,
markets, products, and performance. The matters discussed herein
should not be construed in any way, shape or manner of our future
financial condition or stock price.
Follow us on Twitter and Facebook
CONTACT:
Canbiola
Investor Relations
Email: IR@canbiola.com
Phone: (516) 595-9544
http://www.canbiola.com
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Aug 2024 to Sep 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Sep 2023 to Sep 2024